Vertex Pharmaceuticals Incorporated (LON:0QZU)
London flag London · Delayed Price · Currency is GBP · Price in USD
406.24
-1.23 (-0.30%)
At close: Oct 3, 2025

Vertex Pharmaceuticals Market Cap

Vertex Pharmaceuticals has a market cap or net worth of 76.73 billion as of October 3, 2025. Its market cap has decreased by -17.20% in one year.

Market Cap
76.73B
Enterprise Value
68.94B
Revenue
8.33B
Ranking
n/a
PE Ratio
28.90
Stock Price
406.24

Market Cap Chart

Since July 24, 1991, Vertex Pharmaceuticals's market cap has increased from 51.21M to 76.73B, an increase of 149,729.14%. That is a compound annual growth rate of 23.82%.

History

DateMarket Cap% Change
Oct 3, 202576.73B-7.37%
Dec 31, 202482.84B0.64%
Dec 29, 202382.31B33.80%
Dec 30, 202261.52B49.20%
Dec 31, 202141.23B-8.40%
Dec 31, 202045.01B5.89%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 31, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

CompanyMarket Cap
AstraZeneca196.16B
GSK plc65.55B
Haleon29.53B
Smith & Nephew11.64B
ConvaTec Group4.81B
Hikma Pharmaceuticals4.09B
HUTCHMED (China)2.08B
Genus1.67B
Market Cap Rankings